ASSOCIATION OF N-[(7S)-3,4-DIMETHOXYBICYCLO[4.2.0]OCTA-1,3,5-TRIEN-7- YL]METHYL-3-(7,8-DIMETHOXY-1,2,4,5-TETRAHYDRO-3H-3-BENZAZEPIN-3-YL)-N- METHYL-3-OXO-1-PROPANAMINE AND PERINDOPRIL N-[(7S)-34-[420]-135--7-]-3-(78- -1245--3H-3--3-)-N--3--1

• Main Authors: FELDMANN, Luc, VILAINE, Jean-Paul, THUILLEZ, Christian, FRATACCI, Marie-Dominique, ROUSSEL, Jrme, MULDER, Paulus, LEREBOURS-PIGEONNIERE, Guy
• Format: Patent
• Language: Chinese; English
• Published: 15.04.2016
• Subjects: HUMAN NECESSITIES; HYGIENE; MEDICAL OR VETERINARY SCIENCE; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS

Combination (I) comprises a selective and specific sinusal I f(mixed sodium ion-potassium ion inward current) current inhibitor (A) and an angiotensin converting enzyme inhibitor (B). An independent claim is included for pharmaceutical compositions comprising: ivabradine, in the form of hydrochloride or its hydrate or crystalline forms, and perindopril, in the form of salt of tert-butylamine or arginine or their hydrates or crystalline forms, alone or in combination with one or more excipient. ACTIVITY : Cardiant; Cardiovascular-Gen.; Vasotropic; Antianginal; Antiarrhythmic. MECHANISM OF ACTION : Sinusal I fcurrent inhibitor; Angiotensin converting enzyme inhibitor.